Travere Therapeutics, Inc. Insider Transactions
Travere Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 925 @ $18.94 | $17.52 K | 54,002 | 01/22/2025 | 01/23/2025 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 2,437 @ $19.46 | $47.42 K | 83,170 | 01/22/2025 | 01/23/2025 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 10,736 @ $19.46 | $208.92 K | 351,239 | 01/22/2025 | 01/23/2025 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 2,437 @ $19.46 | $47.42 K | 76,933 | 01/22/2025 | 01/23/2025 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 1,584 @ $18.94 | $30.00 K | 106,374 | 01/22/2025 | 01/23/2025 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 440 @ $18.76 | $8.25 K | 59,443 | 01/06/2025 | 01/06/2025 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 2,066 @ $19.10 | $39.46 K | 59,883 | 01/03/2025 | 01/06/2025 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 15,000 @ $17.22 | $258.28 K | 54,927 | 12/26/2024 | 12/27/2024 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 12,090 @ $18.30 | $221.26 K | 54,927 | 11/25/2024 | 11/25/2024 | |
|
LYONS GARY A
Director |
Sell | 21,179 @ $14.35 | $303.87 K | 69,821 | 10/04/2024 | 10/04/2024 | |
|
LYONS GARY A
Director |
Sell | 18,821 @ $15.15 | $285.23 K | 51,000 | 10/04/2024 | 10/04/2024 | |
|
Meckler Jeffrey A
Director |
Sell | 40,000 @ $14.06 | $562.32 K | 81,000 | 09/30/2024 | 09/30/2024 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 684 @ $12.98 | $8.88 K | 61,949 | 09/10/2024 | 09/10/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 4,387 @ $11.52 | $50.54 K | 84,455 | 09/09/2024 | 09/09/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 4,387 @ $11.52 | $50.54 K | 78,633 | 09/09/2024 | 09/09/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 21,125 @ $11.52 | $243.36 K | 361,975 | 09/09/2024 | 09/09/2024 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 2,191 @ $11.52 | $25.24 K | 62,633 | 09/09/2024 | 09/09/2024 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 2,191 @ $11.52 | $25.24 K | 107,958 | 09/09/2024 | 09/09/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 2,490 @ $11.52 | $28.69 K | 74,595 | 09/09/2024 | 09/09/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 514 @ $9.51 | $4.89 K | 70,335 | 09/04/2024 | 09/05/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Travere Therapeutics, Inc. FAQ's
The list of insiders at Travere Therapeutics, Inc. includes Calvin Sandra, Inrig Jula, ROTE WILLIAM E., Dube Eric M, REED ELIZABETH E, Heerma Peter, Cline Christopher R., Baynes Roy D..
Insiders have sold a total of 207.14 K Travere Therapeutics, Inc. shares in the last 12 months for a total of 4.36 M sold.
The following insiders have sold Travere Therapeutics, Inc. shares in the last 12 months: Calvin Sandra ($949.26 K), Inrig Jula ($214.22 K), ROTE WILLIAM E. ($346.83 K), Dube Eric M ($1.51 M), REED ELIZABETH E ($412.71 K), Heerma Peter ($271.22 K), Cline Christopher R. ($121.48 K), Baynes Roy D. ($540.00 K),